跳到正文
原文
Medical Xpress·· 9 天前AI 评分40

多器官芯片平台揭示心脏对癌症转移的抵抗机制

Why does cancer rarely spread to the heart? Researchers develop organ-on-a-chip platform to find out

AI 导读

多伦多大学研究团队开发了一种多器官芯片平台(MInD),用于研究心脏为何很少成为癌症转移的靶点。研究发现,乳腺癌细胞在模拟心脏组织中侵袭显著减少,而在模拟肝脏组织中侵袭性强。该平台揭示了心脏组织通过改变相关信号通路抑制癌症转移的机制,为癌症研究和药物发现提供了新工具。

正文
Why does cancer rarely spread to the heart? University of Toronto researchers develop organ-on-a-chip platform to find out
University of Toronto researcher Amid Shakeri holding the multi-organ-on-a-chip device. Credit: Amid Shakeri / University of Toronto Engineering

Researchers from the University of Toronto have created a new multi-organ-on-a-chip device to investigate why the heart is one of the least common sites of cancer metastasis, creating new opportunities for cancer research and drug discovery.

The heart's unusual resistance to cancer has long puzzled scientists and may contain important clues for preventing metastasis in other organs. The new multi-organ-on-a-chip platform makes it possible to study this phenomenon in a controlled laboratory setting. Using the platform, the team found that aggressive breast cancer cells readily invaded engineered liver tissue but showed significantly reduced invasion into cardiac tissue.

The platform, called the Multi-organ Invasion Device (MInD), connects multiple engineered tissues within a single system under dynamic fluid flow. It allows researchers to observe how cancer cells move between tissue environments and how each organ influences their behavior. The research team published their findings in Nature Communications.

"The goal was to create a platform that captures key steps of the metastatic process while allowing us to observe interactions between different tissues under controlled conditions," says professor Milica Radisic, the senior author of the study.

"Current models have important limitations, either because they cannot reproduce the complexity of human tissues or because they do not have a good way to connect organ compartments via a common circulation. MInD provides a new way to investigate these interactions."

Connecting tissues to study cancer spread

Metastasis is responsible for more than 90% of cancer-related deaths, but the biological processes that determine where tumor cells spread remain difficult to study. Traditional cell cultures lack the complexity of living tissues, while animal models make it challenging to isolate the effects of individual organs and their microenvironments.

To address these challenges, the researchers engineered MInD as an open-well, multi-organ platform in which different tissues can be cultured simultaneously. The team also developed a new method for manufacturing PermeoTubes using a biodegradable elastic polymer and granular 3D-printing techniques. The tubes contain interconnected pores that support cancer cell migration and biochemical communication between tissues while maintaining mechanical properties similar to those found in native biological structures.

Why does cancer rarely spread to the heart? Researchers develop organ-on-a-chip platform to find out
Metastasis-on-a-chip assay in MInD reveals inhibited cancer cell invasion in cardiac versus hepatic co-culture microenvironments. Credit: Nature Communications (2026). DOI: 10.1038/s41467-026-75833-9

Cardiac tissue curbs cancer cell invasion

The researchers used the platform to compare two very different destinations for metastatic breast cancer cells: engineered cardiac tissue and liver tissue, a common site of breast cancer metastasis. In devices containing either tissue, cancer cells migrated readily toward the liver but showed significantly less invasion into the cardiac tissue.

The difference was even clearer when cardiac tissue, liver tissue and cancer cells were cultured together in the same device. Cancer cells preferentially migrated toward the liver compartment, while the presence of cardiac tissue reduced overall invasion.

The findings demonstrated that the platform could reproduce organ-specific differences in metastatic behavior while providing researchers with detailed insight into the biological signals involved. Analysis of proteins and gene expression revealed that cardiac tissue altered pathways associated with metastasis, immune responses and cell migration, suppressing metastasis to the heart.

"We were able to monitor where cancer cells moved in real time and see how different tissue environments influenced their behavior at the molecular level," says Amid Shakeri, the study's first author.

"MInD gives us a new way to investigate why some tissues resist metastasis while others are more permissive, and it may help identify strategies to limit cancer spread elsewhere in the body."

Beyond cancer research, the team believes the underlying manufacturing approach may also have applications in the broader organ-on-a-chip field, where researchers seek to recreate human physiology in vitro for drug testing and disease modeling.

Publication details

Amid Shakeri et al., In vitro multi-organ invasion model for exploring cardiac resistance to cancer metastasis, Nature Communications (2026). DOI: 10.1038/s41467-026-75833-9

Journal information: Nature Communications

Clinical categories

OncologyCardiology

Who's behind this story?

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Why does cancer rarely spread to the heart? Researchers develop organ-on-a-chip platform to find out (2026, November 10) retrieved 10 November 2026 from https://medicalxpress.com/news/2026-11-cancer-rarely-heart-chip-platform.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com